Literature DB >> 30578090

Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology.

Sofie Voet1, Marco Prinz2, Geert van Loo3.   

Abstract

Microglia are the resident macrophages of the central nervous system (CNS). They have important physiological functions in maintaining tissue homeostasis but also contribute to CNS pathology. Microglia respond to changes in the microenvironment, and the resulting reactive phenotype can be very diverse, with both neuroinflammatory and neuroprotective properties, illustrating the plasticity of these cells. Recent progress in understanding the autoimmune neuroinflammatory disease multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis suggests major roles for microglia in the disease, which have drastically changed our view on the function of microglia in MS.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CNS; microglia; multiple sclerosis; neuroinflammation

Year:  2018        PMID: 30578090     DOI: 10.1016/j.molmed.2018.11.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  99 in total

Review 1.  White matter and neurological disorders.

Authors:  Han-Gyu Bae; Tai Kyoung Kim; Ho Young Suk; Sangyoung Jung; Dong-Gyu Jo
Journal:  Arch Pharm Res       Date:  2020-09-25       Impact factor: 4.946

2.  miR-34b-3p Inhibition of eIF4E Causes Post-stroke Depression in Adult Mice.

Authors:  Xiao Ke; Manfei Deng; Zhuoze Wu; Hongyan Yu; Dian Yu; Hao Li; Youming Lu; Kai Shu; Lei Pei
Journal:  Neurosci Bull       Date:  2022-07-08       Impact factor: 5.203

3.  Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection.

Authors:  Alan Sariol; Samantha Mackin; Merri-Grace Allred; Chen Ma; Yu Zhou; Qinran Zhang; Xiufen Zou; Juan E Abrahante; David K Meyerholz; Stanley Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

4.  Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling.

Authors:  Pernille M Madsen; Haritha L Desu; Juan Pablo de Rivero Vaccari; Yoleinny Florimon; Ditte G Ellman; Robert W Keane; Bettina H Clausen; Kate L Lambertsen; Roberta Brambilla
Journal:  Brain Behav Immun       Date:  2019-11-27       Impact factor: 7.217

Review 5.  The Gut-CNS Axis in Multiple Sclerosis.

Authors:  Atsushi Kadowaki; Francisco J Quintana
Journal:  Trends Neurosci       Date:  2020-07-07       Impact factor: 13.837

Review 6.  Diversity and Function of Glial Cell Types in Multiple Sclerosis.

Authors:  Lucas Schirmer; Dorothy P Schafer; Theresa Bartels; David H Rowitch; Peter A Calabresi
Journal:  Trends Immunol       Date:  2021-02-13       Impact factor: 16.687

Review 7.  Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

Authors:  Ajay Uprety; Yeji Kang; Soo Young Kim
Journal:  Arch Pharm Res       Date:  2021-05-24       Impact factor: 4.946

8.  CHRFAM7A Overexpression Attenuates Cerebral Ischemia-Reperfusion Injury via Inhibiting Microglia Pyroptosis Mediated by the NLRP3/Caspase-1 pathway.

Authors:  Xiangyuan Cao; Yida Wang; Liang Gao
Journal:  Inflammation       Date:  2021-01-06       Impact factor: 4.092

9.  Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation.

Authors:  Efrat Abramson; Clayton Hardman; Akira J Shimizu; Soonmyung Hwang; Lynda D Hester; Solomon H Snyder; Paul A Wender; Paul M Kim; Michael D Kornberg
Journal:  Cell Chem Biol       Date:  2021-01-19       Impact factor: 8.116

Review 10.  Microglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities.

Authors:  Junxuan Lyu; Xiaoyan Jiang; Rehana K Leak; Yejie Shi; Xiaoming Hu; Jun Chen
Journal:  Transl Stroke Res       Date:  2020-10-31       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.